At 12.9x earnings, AZZ screens optically cheap, but the 20.3x forward P/E and a stretched 4.4 PEG Forward tell a very different story: the market is discounting a sharp deceleration or overestimating forward growth relative to price. The balance sheet is undeniably safe with an Altman Z-Score of 4.4 and a manageable 15.30% Debt/Equity ratio, removing bankruptcy risk from the equation. However, with Return on Equity at just 6.20% versus a far stronger 20.30% ROIC, capital deployment efficiency is uneven, suggesting structural reinvestment constraints. This is not distressed, but it is not screamingly undervalued either — it is a stable compounder priced for moderation rather than acceleration.